There are no clearly defined, widely accepted clinical pharmacist metrics.
Jessica M. Lewis-Gonzalez, PharmD, BCOP
Advertisement
Articles by Jessica M. Lewis-Gonzalez, PharmD, BCOP
Relapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Breaking News: AstraZeneca, White House Announce Most-Favored-Nation Deal
2
New Report Details Rising Incidence of Invasive Lobular Carcinoma
3
Tramadol and Antidepressants Linked to Increased Seizure Risk in Older Adults
4
FDA Approves Expanded Indication for Risperidone Extended-Release Injectable to Treat Bipolar I Disorder
5
